1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Groove Botanicals, Inc.

Groove Botanicals, Inc.

GRVE
Groove Botanicals, Inc.US flagOther OTC
0.00
USD
- -
- -
238,572.00Market Cap
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
1.67
0.65
0.16
0.07
0.05
0.02
0.01
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-12.6
-5.73
-1.13
-0.21
-0.23
-0.08
-0.01
-0.15
-0.03
- -
-0.01
-0.01
- -
-0.01
Free Cash Flow per Basic Share
-6.11
-0.12
-0.58
-0.16
-0.1
-0.04
-0.03
-0.02
-0.01
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
0.01
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-129.09
-66.93
-23.34
-8.03
-8.63
-3.08
-2.43
-1.91
-1.87
-0.64
-0.59
-0.59
- -
-0.6
Tangible Book Value per Share
5.22
0.44
0.27
-0.03
0.09
0.11
0.13
-0.03
-0.05
-0.01
-0.01
-0.02
- -
-0.02
Basic Weighted Avg Shares
- -
- -
1
4
3
10
13
18
18
54
59
60
- -
60
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
-553.3
-420.51
-635.83
-190.54
-351.19
-411.37
-338.94
-1,646.54
-371.01
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-2
-2
-1
-1
-1
-1
- -
-3
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-742.42
-865.44
-700.46
-290.35
-458.09
-502.79
90.89
-4,730.2
-411.75
- -
- -
- -
- -
- -
Working Capital
-1
-1
-1
-1
-1
- -
- -
-1
-1
- -
-1
-1
-1
-1
LT Debt
- -
- -
- -
- -
1
1
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
2
1
1
1
- -
1
2
-1
-1
- -
-1
-1
-1
-1
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
-21.07
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
-0.47
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
60
60
60
Market Capitalization
- -
1
1

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
1
Payables & Accruals
1
1
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
17.32%
32.12%
32.29%
Free Cash Flow
-13.19%
-15.64%
-14.67%
Net Income, GAAP
-284.63%
-20.03%
6.94%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
-0.01
2025
- -
- -
- -
- -
-0.01
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Kent A. Rodriguez
Full Time Employees
1
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
310 Fourth Avenue South Minneapolis MN United States of America 55415
IPO Date
Sep 25, 2012
CIK
0000918573
Website
groovebotanicals.com
Similar Companies
Aida Pharmaceuticals, Inc. (AIDA)
Zydus Lifesciences Limited (ZYDUSLIFE.NS)
Capha Pharmaceuticals Inc. (FPSUF)
J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.BO)
THC Biomed Intl Ltd. (THCBF)
Percheron Therapeutics Limited (PER.AX)
Business
Groove Botanicals, Inc. (GRVE) operates as a Nevada-incorporated development-stage company with no significant current operations; it previously focused on assembling a portfolio of early-stage electric vehicle (EV) battery technologies sourced from universities in Norway, Sweden, and Finland while pursuing grants from the State of Minnesota Department of Economic Development. Founded in 1991 as Snow Runner (USA), Inc. and formerly known as Avalon Oil & Gas, Inc., the company changed its name to Groove Botanicals, Inc. in May 2018 to pivot toward consumer health products, including the production, marketing, distribution, and sale of personal grooming products and cosmetics containing cannabidiol (CBD) extracted from hemp, such as its proprietary CB3 Skincare line featuring Revita Wash, Phyto Lotion, and Eye Matter; these offerings emphasize premium hemp extracts with broad cannabinoids, are 100% American-made, non-toxic, paraben-free, vegan, and pet-friendly, targeting skincare routines for all skin types. Headquartered at 310 Fourth Avenue South, Suite 7000, Minneapolis, Minnesota, the company maintains minimal operations with two employees under CEO Kent A. Rodriguez, and it has issued shares for services like website development as recently as February 2023 while reporting earnings for quarters through September 30, 2025 with no research and development expenditures; earlier efforts included partnerships with CBD research, cultivation, and extraction leaders announced in 2018, an exclusive licensing agreement for hemp and Curcuma plant-based products in 2020, and a new website launch to enable pre-orders of its CBD skincare line.

Company News

APIChatGPT

  • defenseworld.net

    Critical Comparison: Mach Natural Resources (NYSE:MNR) vs. Avalon Oil & Gas (OTCMKTS:GRVE)